Clinical Trial Update: Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole [Phase 1]

View source ↗

Summary

Phase I trial evaluating safety and pharmacokinetics of oxfendazole for neurocysticercosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocysticercosis

Drugs mentioned

• Oxfendazole (oxfendazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Neurocysticercosis | Phase 1 | Status: COMPLETED | Results posted: 2019-11-26